Lehmann JM, McKee DD, Watson MA, et al: The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest. 102:1016–1023. 1998. View Article : Google Scholar : PubMed/NCBI

Bertilsson G, Heidrich J, Svensson K, et al: Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proc Natl Acad Sci USA. 95:12208–12213. 1998. View Article : Google Scholar : PubMed/NCBI

Kliewer SA, Moore JT, Wade L, et al: An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell. 92:73–82. 1998. View Article : Google Scholar : PubMed/NCBI

Blumberg B, Sabbagh W Jr, Juguilon H, et al: SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes Dev. 12:3195–3205. 1998. View Article : Google Scholar : PubMed/NCBI

Kast HR, Goodwin B, Tarr PT, et al: Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem. 277:2908–2915. 2002. View Article : Google Scholar

Geick A, Eichelbaum M and Burk O: Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J Biol Chem. 276:14581–14587. 2001. View Article : Google Scholar : PubMed/NCBI

Goodwin B, Hodgson E and Liddle C: The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. Mol Pharmacol. 56:1329–1339. 1999.PubMed/NCBI

Kawana K, Ikuta T, Kobayashi Y, Gotoh O, Takeda K and Kawajiri K: Molecular mechanism of nuclear translocation of an orphan nuclear receptor, SXR. Mol Pharmacol. 63:524–531. 2003. View Article : Google Scholar : PubMed/NCBI

Zhang J, Kuehl P, Green ED, Touchman JW, et al: The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants. Pharmacogenetics. 11:555–572. 2001. View Article : Google Scholar : PubMed/NCBI

Renaud JP, Rochel N, Ruff M, Vivat V, Chambon P, Gronemeyer H and Moras D: Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature. 378:681–689. 1995. View Article : Google Scholar : PubMed/NCBI

Xu HE, Stanley TB, Montana VG, et al: Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha. Nature. 415:813–817. 2002. View Article : Google Scholar : PubMed/NCBI

Nolte RT, Wisely GB, Westin S, et al: Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature. 395:137–143. 1998. View Article : Google Scholar : PubMed/NCBI

Watkins RE, Maglich JM, Moore LB, et al: 2.1 A crystal structure of human PXR in complex with the St. John’s wort compound hyperforin. Biochemistry. 42:1430–1438. 2003.

Rosenfeld JM, Vargas R Jr, Xie W and Evans RM: Genetic profiling defines the xenobiotic gene network controlled by the nuclear receptor pregnane X receptor. Mol Endocrinol. 17:1268–1282. 2003. View Article : Google Scholar : PubMed/NCBI

Guengerich FP: Cytochrome P-450 3A4: regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol. 39:1–17. 1999. View Article : Google Scholar

Wrighton SA, Schuetz EG, Thummel KE, Shen DD, Korzekwa KR and Watkins PB: The human CYP3A subfamily: practical considerations. Drug Metab Rev. 32:339–361. 2000. View Article : Google Scholar : PubMed/NCBI

Moore LB, Parks DJ, Jones SA, et al: Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem. 275:15122–15127. 2000. View Article : Google Scholar : PubMed/NCBI

Runge-Morris M, Wu W and Kocarek TA: Regulation of rat hepatic hydroxysteroid sulfotransferase (SULT2-40/41) gene expression by glucocorticoids: evidence for a dual mechanism of transcriptional control. Mol Pharmacol. 56:1198–1206. 1999.

Xie W, Yeuh MF, Radominska-Pandya A, et al: Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor. Proc Natl Acad Sci USA. 100:4150–4155. 2003. View Article : Google Scholar : PubMed/NCBI

Chen C, Staudinger JL and Klaassen CD: Nuclear receptor, pregname X receptor, is required for induction of UDP-glucuronosyltranferases in mouse liver by pregnenolone-16 alpha-carbonitrile. Drug Metab Dispos. 31:908–915. 2003. View Article : Google Scholar : PubMed/NCBI

Yueh MF, Huang YH, Hiller A, Chen S, Nguyen N and Tukey RH: Involvement of the xenobiotic response element (XRE) in Ah receptor-mediated induction of human UDP-glucuronosyltransferase 1A1. J Biol Chem. 278:15001–15006. 2003. View Article : Google Scholar : PubMed/NCBI

Shelby MK and Klaassen CD: Induction of rat UDP-glucuronosyltransferases in liver and duodenum by microsomal enzyme inducers that activate various transcriptional pathways. Drug Metab Dispos. 34:1772–1778. 2006. View Article : Google Scholar : PubMed/NCBI

Vyhlidal CA, Rogan PK and Leeder JS: Development and refinement of pregnane X receptor (PXR) DNA binding site model using information theory: insights into PXR-mediated gene regulation. J Biol Chem. 279:46779–46786. 2004. View Article : Google Scholar : PubMed/NCBI

Buckley DB and Klaassen CD: Induction of mouse UDP-glucuronosyltransferase mRNA expression in liver and intestine by activators of aryl-hydrocarbon receptor, constitutive androstane receptor, pregnane X receptor, peroxisome proliferator-activated receptor alpha, and nuclear factor erythroid 2-related factor 2. Drug Metab Dispos. 37:847–856. 2009.

Synold TW, Dussault I and Forman BM: The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat Med. 7:584–590. 2001. View Article : Google Scholar : PubMed/NCBI

Kast HR, Goodwin B, Tarr PT, et al: Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem. 277:2908–2915. 2002. View Article : Google Scholar

Jones SA, Moore LB, Shenk JL, et al: The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution. Mol Endocrinol. 14:27–39. 2000. View Article : Google Scholar : PubMed/NCBI

Wentworth JM, Agostini M, Love J, Schwabe JW and Chatterjee VK: St John’s wort, a herbal antidepressant, activates the steroid X receptor. J Endocrinol. 166:R11–R16. 2000.

Savas U, Wester MR, Griffin KJ and Johnson EF: Rabbit pregnane X receptor is activated by rifampicin. Drug Metab Dispos. 28:529–537. 2000.PubMed/NCBI

Zhang H, LeCulyse E, Liu L, Hu M, Matoney L, Zhu W and Yan B: Rat pregnane X receptor: molecular cloning, tissue distribution, and xenobiotic regulation. Arch Biochem Biophys. 368:14–22. 1999. View Article : Google Scholar : PubMed/NCBI

Cheng X and Klaassen CD: Regulation of mRNA expression of xenobiotic transporters by the pregnane X receptor in mouse liver, kidney, and intestine. Drug Metab Dispos. 34:1863–1867. 2006. View Article : Google Scholar : PubMed/NCBI

Bauer B, Hartz AM, Fricker G and Miller DS: Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood-brain barrier. Mol Pharmacol. 66:413–419. 2004.PubMed/NCBI

Chirulli V, Longo V, Marini S, Mazzaccaro A, Fiorio R and Gervasi PG: CAR and PXR expression and inducibility of CYP2B and CYP3A activities in rat and rabbit lungs. Life Sci. 76:2535–2546. 2005. View Article : Google Scholar : PubMed/NCBI

Staudinger JL, Goodwin B, Jones SA, et al: The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci USA. 98:3369–3374. 2001. View Article : Google Scholar : PubMed/NCBI

Masuyama H, Hiramatsu Y, Mizutani Y, Inoshita H and Kudo T: The expression of pregnane X receptor and its target gene, cytochrome P450 3A1, in perinatal mouse. Mol Cell Endocrinol. 172:47–56. 2001. View Article : Google Scholar : PubMed/NCBI

Dubrac S, Elentner A, Ebner S, Horejs-Hoeck J and Schmuth M: Modulation of T lymphocyte function by the pregnane X receptor. J Immunol. 184:2949–2957. 2010. View Article : Google Scholar : PubMed/NCBI

Owen A, Chandler B, Back DJ and Khoo SH: Expression of pregnane-X-receptor transcript in peripheral blood mononuclear cells and correlation with MDR1 mRNA. Antivir Ther. 9:819–821. 2004.PubMed/NCBI

Albermann N, Schmitz-Winnenthal FH, Z’graggen K, et al: Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver. Biochem Pharmacol. 70:949–958. 2005. View Article : Google Scholar : PubMed/NCBI

Lamba V, Yasuda K, Lamba JK, Assem M, Davila J, Strom S and Schuetz EG: PXR (NR1I2): splice variants in human tissues, including brain, and identification of neurosteroids and nicotine as PXR activators. Toxicol Appl Pharmacol. 199:251–265. 2004. View Article : Google Scholar : PubMed/NCBI

Dotzlaw H, Leygue E, Watson P and Murphy LC: The human orphan receptor PXR messenger RNA is expressed in both normal and neoplastic breast tissue. Clin Cancer Res. 5:2103–2107. 1999.PubMed/NCBI

Miki Y, Suzuki T, Kitada K, et al: Expression of the steroid and xenobiotic receptor and its possible target gene, organic anion transporting polypeptide-A, in human breast carcinoma. Cancer Res. 66:535–542. 2006. View Article : Google Scholar : PubMed/NCBI

Mensah-Osman EJ, Thomas DG, Tabb MM, et al: Expression levels and activation of a PXR variant are directly related to drug resistance in osteosarcoma cell lines. Cancer. 109:957–965. 2007. View Article : Google Scholar : PubMed/NCBI

Zhou J, Liu M, Zhai Y and Xie W: The antiapoptotic role of pregnane X receptor in human colon cancer cells. Mol Endocrinol. 22:868–880. 2008. View Article : Google Scholar : PubMed/NCBI

Masuyama H, Hiramatsu Y, Kodama J and Kudo T: Expression and potential roles of pregnane X receptor in endometrial cancer. J Clin Endocrinol Metab. 88:4446–4454. 2003. View Article : Google Scholar : PubMed/NCBI

Masuyama H, Nakatsukasa H, Takamoto N and Hiramatsu Y: Down-regulation of pregnane X receptor contributes to cell growth inhibition and apoptosis by anticancer agents in endometrial cancer cells. Mol Pharmacol. 72:1045–1053. 2007. View Article : Google Scholar : PubMed/NCBI

Gupta D, Venkatesh M, Wang H, et al: Expanding the roles for pregnane X receptor in cancer: proliferation and drug resistance in ovarian cancer. Clin Cancer Res. 14:5332–5340. 2008. View Article : Google Scholar : PubMed/NCBI

Chen Y, Tang Y, Wang MT, Zeng S and Nie D: Human pregnane X receptor and resistance to chemotherapy in prostate cancer. Cancer Res. 67:10361–10367. 2007. View Article : Google Scholar : PubMed/NCBI

Takeyama D, Miki Y, Fujishima F, Suzuki T, Akahira J, Hata S, Miyata G, Satomi S and Sasano H: Steroid and xenobiotic receptor in human esophageal squamous cell carcinoma: a potent prognostic factor. Cancer Sci. 101:543–549. 2010. View Article : Google Scholar : PubMed/NCBI

Pfrunder A, Gutmann H, Beglinger C and Drewe J: Gene expression of CYP3A4, ABC-transporters (MDR1 and MRP1-MRP5) and hPXR in three different human colon carcinoma cell lines. J Pharm Pharmacol. 55:59–66. 2003. View Article : Google Scholar : PubMed/NCBI

Jiang H, Chen K, He J, Pan F, Li J, Chen J, Chen W and Liang H: Association of pregnane X receptor with multidrug resistance-related protein 3 and its role in human colon cancer chemoresistance. J Gastrointest Surg. 13:1831–1838. 2009. View Article : Google Scholar : PubMed/NCBI

Harmsen S, Meijerman I, Febus CL, Maas-Bakker RF, Beijnen JH and Schellens JH: PXR-mediated induction of P-glycoprotein by anticancer drugs in a human colon adeno-carcinoma-derived cell line. Cancer Chemother Pharmacol. 66:765–771. 2010. View Article : Google Scholar : PubMed/NCBI

Habano W, Gamo T, Terashima J, Sugai T, Otsuka K, Wakabayashi G and Ozawa S: Involvement of promoter methylation in the regulation of pregnane X receptor in colon cancer cells. BMC Cancer. 11:812011. View Article : Google Scholar : PubMed/NCBI

Raynal C, Pascussi JM, Leguelinel G, et al: Pregnane X Receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidation. Mol Cancer. 9:462010. View Article : Google Scholar : PubMed/NCBI

Basseville A, Preisser L, de Carné Trécesson S, Boisdron-Celle M, Gamelin E, Coqueret O and Morel A: Irinotecan induces steroid and xenobiotic receptor (SXR) signaling to detoxification pathway in colon cancer cells. Mol Cancer. 10:802011. View Article : Google Scholar : PubMed/NCBI

Zheng XE, Wang Z, Liao MZ, Lin YS, Shuhart MC, Schuetz EG and Thummel KE: Human PXR-mediated induction of intestinal CYP3A4 attenuates 1α,25-dihydroxyvitamin D₃ function in human colon adenocarcinoma LS180 cells. Biochem Pharmacol. 84:391–401. 2012.PubMed/NCBI

Wang H, Venkatesh M, Li H, et al: Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice. J Clin Invest. 121:3220–3232. 2011. View Article : Google Scholar : PubMed/NCBI

Khan F, Amatya B, Ng L, Demetrios M, Zhang NY and Turner-Stokes L: Multidisciplinary rehabilitation for follow-up of women treated for breast cancer. Cochrane Database Syst Rev. 12:CD0095532012.PubMed/NCBI

Conde I, Lobo MV, Zamora J, Pérez J, González FJ, Alba E, Fraile B, Paniagua R and Arenas MI: Human pregnane X receptor is expressed in breast carcinomas, potential heterodimers formation between hPXR and RXR-alpha. BMC Cancer. 8:1742008. View Article : Google Scholar : PubMed/NCBI

Meyer zu Schwabedissen HE, Tirona RG, Yip CS, Ho RH and Kim RB: Interplay between the nuclear receptor pregnane X receptor and the uptake transporter organic anion transporter polypeptide 1A2 selectively enhances estrogen effects in breast cancer. Cancer Res. 68:9338–9347. 2008.

Sandanaraj E, Lal S, Selvarajan V, Ooi LL, Wong ZW, Wong NS, Ang PC, Lee EJ and Chowbay B: PXR pharmacogenetics: association of haplotypes with hepatic CYP3A4 and ABCB1 messenger RNA expression and doxorubicin clearance in Asian breast cancer patients. Clin Cancer Res. 14:7116–7126. 2008. View Article : Google Scholar : PubMed/NCBI

Choi HK, Yang JW, Roh SH, Han CY and Kang KW: Induction of multidrug resistance associated protein 2 in tamoxifen-resistant breast cancer cells. Endocr Relat Cancer. 14:293–303. 2007. View Article : Google Scholar : PubMed/NCBI

Chen Y, Tang Y, Chen S and Nie D: Regulation of drug resistance by human pregnane X receptor in breast cancer. Cancer Biol Ther. 8:1265–1272. 2009. View Article : Google Scholar : PubMed/NCBI

Masuyama H, Suwaki N, Tateishi Y, Nakatsukasa H, Segawa T and Hiramatsu Y: The pregnane X receptor regulates gene expression in a ligand-and promoter-selective fashion. Mol Endocrinol. 19:1170–1180. 2005. View Article : Google Scholar : PubMed/NCBI

Takami N, Sakamoto H and Yamamoto T: Steroid and xenobiotic receptor (SXR) is a key system for the acquisition of cisplatin resistance in endometrial cancer cells. J Int Med Res. 31:59–68. 2003. View Article : Google Scholar : PubMed/NCBI

Yue X, Akahira J, Utsunomiya H, et al: Steroid and Xenobiotic Receptor (SXR) as a possible prognostic marker in epithelial ovarian cancer. Pathol Int. 60:400–406. 2010. View Article : Google Scholar : PubMed/NCBI

Zhang B, Cheng Q, Ou Z, et al: Pregnane X receptor as a therapeutic target to inhibit androgen activity. Endocrinology. 151:5721–5729. 2010. View Article : Google Scholar : PubMed/NCBI

Fujimura T, Takahashi S, Urano T, et al: Clinical significance of steroid and xenobiotic receptor and its targeted gene CYP3A4 in human prostate cancer. Cancer Sci. 103:176–180. 2012. View Article : Google Scholar : PubMed/NCBI

Maruyama M, Matsunaga T, Harada E and Ohmori S: Comparison of basal gene expression and induction of CYP3As in HepG2 and human fetal liver cells. Biol Pharm Bull. 30:2091–2097. 2007. View Article : Google Scholar : PubMed/NCBI

Azuma K, Urano T, Ouchi Y and Inoue S: Vitamin K2 suppresses proliferation and motility of hepatocellular carcinoma cells by activating steroid and xenobiotic receptor. Endocr J. 56:843–849. 2009. View Article : Google Scholar : PubMed/NCBI

Kodama S and Negishi M: Pregnane X receptor PXR activates the GADD45beta gene, eliciting the p38 MAPK signal and cell migration. J Biol Chem. 286:3570–3578. 2011. View Article : Google Scholar : PubMed/NCBI

van de Winkel A, Menke V, Capello A, et al: Expression, localization and polymorphisms of the nuclear receptor PXR in Barrett’s esophagus and esophageal adenocarcinoma. BMC Gastroenterol. 11:1082011.PubMed/NCBI

van de Winkel A, van Zoest KP, van Dekken H, Moons LM, Kuipers EJ and van der Laan LJ: Differential expression of the nuclear receptors farnesoid X receptor (FXR) and pregnane X receptor (PXR) for grading dysplasia in patients with Barrett’s oesophagus. Histopathology. 58:246–253. 2011.PubMed/NCBI

Kawai M, Chen J, Cheung CY and Chang TK: Transcript profiling of cytochrome P450 genes in HL-60 human leukemic cells: upregulation of CYP1B1 by all-trans-retinoic acid. Mol Cell Biochem. 248:57–65. 2003. View Article : Google Scholar : PubMed/NCBI

Wang T, Ma X, Krausz KW, Idle JR and Gonzalez FJ: Role of pregnane X receptor in control of all-trans retinoic acid (ATRA) metabolism and its potential contribution to ATRA resistance. J Pharmacol Exp Ther. 324:674–684. 2008. View Article : Google Scholar : PubMed/NCBI

Zucchini N, de Sousa G, Bailly-Maitre B, Gugenheim J, Bars R, Lemaire G and Rahmani R: Regulation of Bcl-2 and Bcl-xL anti-apoptotic protein expression by nuclear receptor PXR in primary cultures of human and rat hepatocytes. Biochim Biophys Acta. 1745:48–58. 2005. View Article : Google Scholar : PubMed/NCBI

Wang K, Damjanov I and Wan YJ: The protective role of pregnane X receptor in lipopolysaccharide/D-galactosamine-induced acute liver injury. Lab Invest. 90:257–265. 2010. View Article : Google Scholar : PubMed/NCBI

Ouyang N, Ke S, Eagleton N, Xie Y, Chen G, Laffins B, Yao H, Zhou B and Tian Y: Pregnane X receptor suppresses proliferation and tumourigenicity of colon cancer cells. Br J Cancer. 102:1753–1761. 2010. View Article : Google Scholar : PubMed/NCBI

Verma S, Tabb MM and Blumberg B: Activation of the steroid and xenobiotic receptor, SXR, induces apoptosis in breast cancer cells. BMC Cancer. 9:32009. View Article : Google Scholar : PubMed/NCBI

Liu C, Li J, Wang L, Wu F, Huang L, Xu Y, Ye J, Xiao B, Meng F, Chen S and Yang M: Analysis of tanshinone IIA induced cellular apoptosis in leukemia cells by genome-wide expression profiling. BMC Complement Altern Med. 12:52012. View Article : Google Scholar : PubMed/NCBI

Zimmermann K, Wittman MD, Saulnier MG, et al: SAR of PXR transactivation in benzimidazole-based IGF-1R kinase inhibitors. Bioorg Med Chem Lett. 20:1744–1748. 2010. View Article : Google Scholar : PubMed/NCBI

Healan-Greenberg C, Waring JF, Kempf DJ, Blomme EA, Tirona RG and Kim RB: A human immunodeficiency virus protease inhibitor is a novel functional inhibitor of human pregnane X receptor. Drug Metab Dispos. 36:500–507. 2008. View Article : Google Scholar : PubMed/NCBI

Huang H, Wang H, Sinz M, et al: Inhibition of drug metabolism by blocking the activation of nuclear receptors by ketoconazole. Oncogene. 26:258–268. 2007. View Article : Google Scholar : PubMed/NCBI

Zhou C, Poulton EJ, Grün F, Bammler TK, Blumberg B, Thummel KE and Eaton DL: The dietary isothiocyanate sulforaphane is an antagonist of the human steroid and xenobiotic nuclear receptor. Mol Pharmacol. 71:220–229. 2007. View Article : Google Scholar : PubMed/NCBI

Kliewer SA, Goodwin B and Willson TM: The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr Rev. 23:687–702. 2002. View Article : Google Scholar : PubMed/NCBI